STOCK TITAN

[Form 4] Stoke Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Upstart Holdings, Inc. (UPST) – Form 144 insider notice

Insider Natalia Mirgorodskaya has filed to sell up to 6,533 common shares through Charles Schwab on or about 07/02/2025. At the reference price used in the filing, the transaction is valued at roughly $457,674. The shares were obtained the same day via an employee stock-option cashless exercise. Mirgorodskaya also disclosed two prior sales in the last three months—764 shares for $35,874 on 05/20/2025 and 1,340 shares for $59,215 on 05/23/2025.

With 95,144,858 shares outstanding, the proposed sale represents approximately 0.007 % of total shares, indicating a limited potential impact on the float. The filer certified that no undisclosed adverse information is known, in accordance with Rule 144 requirements.

Upstart Holdings, Inc. (UPST) – Comunicazione interna Form 144

L'insider Natalia Mirgorodskaya ha presentato una richiesta di vendita fino a 6.533 azioni ordinarie tramite Charles Schwab intorno al 02/07/2025. Al prezzo di riferimento indicato nella comunicazione, l'operazione ha un valore approssimativo di 457.674 $. Le azioni sono state ottenute lo stesso giorno mediante un esercizio senza esborso di opzioni azionarie per dipendenti. Mirgorodskaya ha inoltre dichiarato due vendite precedenti negli ultimi tre mesi: 764 azioni per 35.874 $ il 20/05/2025 e 1.340 azioni per 59.215 $ il 23/05/2025.

Con un totale di 95.144.858 azioni in circolazione, la vendita proposta rappresenta circa lo 0,007% del totale delle azioni, indicando un impatto potenziale limitato sulla flottante. Il dichiarante ha certificato di non essere a conoscenza di informazioni negative non divulgate, in conformità ai requisiti della Regola 144.

Upstart Holdings, Inc. (UPST) – Aviso interno Formulario 144

La insider Natalia Mirgorodskaya ha presentado una solicitud para vender hasta 6,533 acciones comunes a través de Charles Schwab alrededor del 02/07/2025. Al precio de referencia utilizado en la presentación, la transacción tiene un valor aproximado de 457,674 $. Las acciones fueron obtenidas el mismo día mediante un ejercicio sin efectivo de opciones sobre acciones para empleados. Mirgorodskaya también reveló dos ventas previas en los últimos tres meses: 764 acciones por 35,874 $ el 20/05/2025 y 1,340 acciones por 59,215 $ el 23/05/2025.

Con 95,144,858 acciones en circulación, la venta propuesta representa aproximadamente el 0,007 % del total de acciones, lo que indica un impacto potencial limitado en el flotante. El declarante certificó que no conoce información adversa no divulgada, conforme a los requisitos de la Regla 144.

업스타트 홀딩스, Inc. (UPST) – Form 144 내부자 공시

내부자 나탈리아 미르고로드스카야가 2025년 7월 2일경 찰스 슈왑을 통해 최대 6,533 보통주를 매도하기 위해 신고했습니다. 신고서에 사용된 기준 가격으로 거래 가치는 약 457,674 달러에 달합니다. 해당 주식은 같은 날 직원 주식매수선택권 무현금 행사를 통해 취득되었습니다. 미르고로드스카야는 또한 지난 3개월 동안 두 차례 매도 내역을 공개했으며, 각각 2025년 5월 20일 764주, 35,874달러2025년 5월 23일 1,340주, 59,215달러입니다.

95,144,858 주 발행 기준으로 이번 매도는 전체 주식의 약 0.007%에 해당하며, 유통 주식에 미치는 영향은 제한적일 것으로 보입니다. 신고자는 Rule 144 요건에 따라 미공개 부정적 정보가 없음을 인증했습니다.

Upstart Holdings, Inc. (UPST) – Avis d’initié Formulaire 144

L’initiée Natalia Mirgorodskaya a déposé une demande pour vendre jusqu’à 6 533 actions ordinaires via Charles Schwab aux alentours du 02/07/2025. Au prix de référence utilisé dans le dépôt, la transaction est évaluée à environ 457 674 $. Les actions ont été obtenues le même jour par un exercice sans décaissement d’options d’achat d’actions employé. Mirgorodskaya a également divulgué deux ventes antérieures au cours des trois derniers mois : 764 actions pour 35 874 $ le 20/05/2025 et 1 340 actions pour 59 215 $ le 23/05/2025.

Avec 95 144 858 actions en circulation, la vente proposée représente environ 0,007 % du total des actions, indiquant un impact potentiel limité sur le flottant. Le déclarant a certifié qu’aucune information défavorable non divulguée n’est connue, conformément aux exigences de la règle 144.

Upstart Holdings, Inc. (UPST) – Form 144 Insider-Mitteilung

Insider Natalia Mirgorodskaya hat die Absicht gemeldet, bis zu 6.533 Stammaktien über Charles Schwab etwa am 02.07.2025 zu verkaufen. Zum im Antrag angegebenen Referenzpreis hat die Transaktion einen Wert von ungefähr 457.674 $. Die Aktien wurden am selben Tag durch eine barlose Ausübung von Mitarbeiteraktienoptionen erworben. Mirgorodskaya gab außerdem zwei frühere Verkäufe in den letzten drei Monaten an: 764 Aktien für 35.874 $ am 20.05.2025 und 1.340 Aktien für 59.215 $ am 23.05.2025.

Bei 95.144.858 ausstehenden Aktien entspricht der geplante Verkauf etwa 0,007 % der Gesamtaktien, was auf eine begrenzte potenzielle Auswirkung auf den Streubesitz hinweist. Der Meldende bestätigte, dass keine nicht offengelegten negativen Informationen bekannt sind, gemäß den Anforderungen der Regel 144.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor insider sale; magnitude is immaterial to float—likely neutral for UPST investors.

The Form 144 reveals a planned divestiture of 6,533 shares (~$458k). Relative to 95 million shares outstanding, this equals just 0.007 %, which is far below thresholds that typically influence supply–demand dynamics or signal strategic shifts. The shares stem from a same-day option exercise, suggesting routine liquidity rather than a valuation call. Two earlier sales totaling 2,104 shares were likewise small. Overall, I view the filing as non-impactful and largely procedural, meriting a neutral stance.

Upstart Holdings, Inc. (UPST) – Comunicazione interna Form 144

L'insider Natalia Mirgorodskaya ha presentato una richiesta di vendita fino a 6.533 azioni ordinarie tramite Charles Schwab intorno al 02/07/2025. Al prezzo di riferimento indicato nella comunicazione, l'operazione ha un valore approssimativo di 457.674 $. Le azioni sono state ottenute lo stesso giorno mediante un esercizio senza esborso di opzioni azionarie per dipendenti. Mirgorodskaya ha inoltre dichiarato due vendite precedenti negli ultimi tre mesi: 764 azioni per 35.874 $ il 20/05/2025 e 1.340 azioni per 59.215 $ il 23/05/2025.

Con un totale di 95.144.858 azioni in circolazione, la vendita proposta rappresenta circa lo 0,007% del totale delle azioni, indicando un impatto potenziale limitato sulla flottante. Il dichiarante ha certificato di non essere a conoscenza di informazioni negative non divulgate, in conformità ai requisiti della Regola 144.

Upstart Holdings, Inc. (UPST) – Aviso interno Formulario 144

La insider Natalia Mirgorodskaya ha presentado una solicitud para vender hasta 6,533 acciones comunes a través de Charles Schwab alrededor del 02/07/2025. Al precio de referencia utilizado en la presentación, la transacción tiene un valor aproximado de 457,674 $. Las acciones fueron obtenidas el mismo día mediante un ejercicio sin efectivo de opciones sobre acciones para empleados. Mirgorodskaya también reveló dos ventas previas en los últimos tres meses: 764 acciones por 35,874 $ el 20/05/2025 y 1,340 acciones por 59,215 $ el 23/05/2025.

Con 95,144,858 acciones en circulación, la venta propuesta representa aproximadamente el 0,007 % del total de acciones, lo que indica un impacto potencial limitado en el flotante. El declarante certificó que no conoce información adversa no divulgada, conforme a los requisitos de la Regla 144.

업스타트 홀딩스, Inc. (UPST) – Form 144 내부자 공시

내부자 나탈리아 미르고로드스카야가 2025년 7월 2일경 찰스 슈왑을 통해 최대 6,533 보통주를 매도하기 위해 신고했습니다. 신고서에 사용된 기준 가격으로 거래 가치는 약 457,674 달러에 달합니다. 해당 주식은 같은 날 직원 주식매수선택권 무현금 행사를 통해 취득되었습니다. 미르고로드스카야는 또한 지난 3개월 동안 두 차례 매도 내역을 공개했으며, 각각 2025년 5월 20일 764주, 35,874달러2025년 5월 23일 1,340주, 59,215달러입니다.

95,144,858 주 발행 기준으로 이번 매도는 전체 주식의 약 0.007%에 해당하며, 유통 주식에 미치는 영향은 제한적일 것으로 보입니다. 신고자는 Rule 144 요건에 따라 미공개 부정적 정보가 없음을 인증했습니다.

Upstart Holdings, Inc. (UPST) – Avis d’initié Formulaire 144

L’initiée Natalia Mirgorodskaya a déposé une demande pour vendre jusqu’à 6 533 actions ordinaires via Charles Schwab aux alentours du 02/07/2025. Au prix de référence utilisé dans le dépôt, la transaction est évaluée à environ 457 674 $. Les actions ont été obtenues le même jour par un exercice sans décaissement d’options d’achat d’actions employé. Mirgorodskaya a également divulgué deux ventes antérieures au cours des trois derniers mois : 764 actions pour 35 874 $ le 20/05/2025 et 1 340 actions pour 59 215 $ le 23/05/2025.

Avec 95 144 858 actions en circulation, la vente proposée représente environ 0,007 % du total des actions, indiquant un impact potentiel limité sur le flottant. Le déclarant a certifié qu’aucune information défavorable non divulguée n’est connue, conformément aux exigences de la règle 144.

Upstart Holdings, Inc. (UPST) – Form 144 Insider-Mitteilung

Insider Natalia Mirgorodskaya hat die Absicht gemeldet, bis zu 6.533 Stammaktien über Charles Schwab etwa am 02.07.2025 zu verkaufen. Zum im Antrag angegebenen Referenzpreis hat die Transaktion einen Wert von ungefähr 457.674 $. Die Aktien wurden am selben Tag durch eine barlose Ausübung von Mitarbeiteraktienoptionen erworben. Mirgorodskaya gab außerdem zwei frühere Verkäufe in den letzten drei Monaten an: 764 Aktien für 35.874 $ am 20.05.2025 und 1.340 Aktien für 59.215 $ am 23.05.2025.

Bei 95.144.858 ausstehenden Aktien entspricht der geplante Verkauf etwa 0,007 % der Gesamtaktien, was auf eine begrenzte potenzielle Auswirkung auf den Streubesitz hinweist. Der Meldende bestätigte, dass keine nicht offengelegten negativen Informationen bekannt sind, gemäß den Anforderungen der Regel 144.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LEVIN ARTHUR A

(Last) (First) (Middle)
C/O STOKE THERAPEUTICS, INC.
45 WIGGINS AVENUE

(Street)
BEDFORD MA 01730

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Stoke Therapeutics, Inc. [ STOK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/30/2025 M 1,210 A $0 2,420 D
Common Stock 17,979 I Arthur A. Levin, Ph.D., Trustee, Butler-Levin Revocable Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 06/30/2025 M 1,210 (2) 12/31/2025 Common Stock 1,210 $0 2,422 D
Explanation of Responses:
1. Each Restricted Stock Unit represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
2. The award vested or vests as to 1/4 of the total award quarterly on the last day of March, June, September, and December, subject to the reporting person's continued service to the issuer through each vesting date.
/s/ Jonathan Allan, Attorney-in-Fact 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Upstart (UPST) shares are covered by this Form 144 filing?

The filing covers 6,533 common shares that the insider intends to sell.

What is the estimated market value of the planned UPST share sale?

The aggregate market value noted in the filing is approximately $457,674.

When is the insider planning to sell the UPST shares?

The approximate sale date listed is 07/02/2025.

How were the shares being sold acquired?

They were acquired on 07/02/2025 via an employee stock-option cashless exercise.

What percentage of Upstart’s outstanding shares does the sale represent?

The 6,533 shares equal roughly 0.007 % of the 95,144,858 shares outstanding.

Has this insider sold UPST shares recently?

Yes. The insider sold 764 shares on 05/20/2025 and 1,340 shares on 05/23/2025.
Stoke Therapeutics

NASDAQ:STOK

STOK Rankings

STOK Latest News

STOK Latest SEC Filings

STOK Stock Data

644.79M
52.07M
4.67%
110.52%
21.1%
Biotechnology
Pharmaceutical Preparations
Link
United States
BEDFORD